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Appendix 1: Additional figures 
 
Appendix Figure 1: Map of Malawi, study sites marked in red 
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Appendix Figure 2: Site 1 pre-vaccination cohort flow diagram per STROBE guidelines 
 
 
  
Excluded from analysis - death  
- Missing dates = 0 
- Migrated = 5 
- No consent = 0 
- No event = 1 
- Record error = 2 
- Household not located = 0 
Livebirths registered: 10,154 
Follow-ups initiated: 9,425 
Follow-up not completed: 44 
Follow-ups complete: 9,381 
Excluded from analysis - survivors  
- Missing dates = 0 
- Migrated = 1,238 
- No consent = 10 
- No event = 3 
- Record error = 58 
- Household not located =  246 
Excluded due to data issues:  
- ID error = 506 
- Suspected duplicate = 47 
- Implausible birth = 16 
- Unknown issue = 2 
  
Not eligible for cohort: 
- Neonatal deaths = 140 
- Early infant deaths = 18 
7,818 included in analysis:  
Surviving = 7,690 
Deceased = 128 
Diarrhoeal deaths = 44 
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Appendix Figure 3: Poisson model predicted diarrhoea-associated mortality vs vaccine coverage, Site 1. 
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Appendix 2: Sensitivity survival analyses, Site 1 
 
2.1 InterVA defined diarrhoea outcome (10wk survival) 
Variable 
Hazard 
Ratio 
95% Confidence 
Interval 
p-value 
RV status 0 doses 
2 doses 
1·00 
0·71 
 
0·21 
 
2·35 
 
0·574 
Mother’s status Married 
Single 
Divorced/widow 
Deceased 
1·00 
2·34 
1·85 
66·60 
 
0·79 
0·54 
8·93 
 
6·93 
6·34 
469·80 
 
0·126 
0·330 
<0·001 
Mother’s education None 
Primary 
Secondary/Tertiary 
1·00 
0·57 
0·44 
 
0·23 
0·10 
 
1·42 
1·89 
 
0·230 
0·271 
Water source                  
 
Protected source 
Open source 
1·00 
1·03 
 
0·42 
 
2·53 
 
0·942 
Toilet facility None 
Some facility 
1·00 
0·94 
 
0·40 
 
2·24 
 
0·890 
House quality Worst 
Middle 
Best 
1·00 
0·88 
2·62 
 
0·26 
0·83 
 
3·00 
8·29 
 
0·842 
0·101 
Household asset index 0·69 0·48 0·99 0·041 
Global test of proportional hazards: 0·2942 
Infants eligible for inclusion in this sensitivity analysis: 27,912 survived, 31 died 
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2.2 Cohort inclusion at 6 week survival 
Variable 
Hazard 
Ratio 
95% Confidence 
Interval 
p-value 
RV status 0 doses 
2 doses 
1·00 
0·57 
 
0·31 
 
1·04 
 
0·066 
Mother’s status Married 
Single 
Divorced/widow 
Deceased 
1·00 
1·85 
1·45 
82·90 
 
0·97 
0·69 
33·40 
 
3·52 
3·06 
205·77 
 
0·061 
0·323 
<0·001 
Mother’s education None 
Primary 
Secondary/Tertiary 
1·00 
1·00 
0·85 
 
0·55 
0·37 
 
1·80 
1·96 
 
0·990 
0·700 
Water source                  
 
Protected source 
Open source 
1·00 
1·42 
 
0·91 
 
2·22 
 
0·122 
Toilet facility None 
Some facility 
1·00 
1·29 
 
0·77 
 
2·17 
 
0·333 
House quality Worst 
Middle 
Best 
1·00 
0·93 
1·65 
 
0·50 
0·82 
 
1·72 
3·33 
 
0·818 
0·161 
Household asset index 0·73 0·61 0·88 0·001 
Global test of proportional hazards: 0·447 
Infants eligible for inclusion in this sensitivity analysis: Survived = 28,342, died = 105 
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2.3 Cohort inclusion at 26 week survival 
Variable 
Hazard 
Ratio 
95% Confidence 
Interval 
p-value 
RV status 0 doses 
2 doses 
1·00 
0·72 
 
0·33 
 
1·58 
 
0·412 
Mother’s status Married 
Single 
Divorced/widow 
Deceased 
1·00 
1·69 
1·92 
136·81 
 
0·76 
0·86 
54·62 
 
3·76 
4·31 
342·69 
 
0·199 
0·111 
<0·001 
Mother’s education None 
Primary 
Secondary/Tertiary 
1·00 
1·17 
1·08 
 
0·56 
0·40 
 
2·47 
2·89 
 
0·675 
0·881 
Water source                  
 
Protected source 
Open source 
1·00 
1·42 
 
0·84 
 
2·39 
 
0·188 
Toilet facility None 
Some facility 
1·00 
1·25 
 
0·68 
 
2·30 
 
0·471 
House quality Worst 
Middle 
Best 
1·00 
0·93 
1·44 
 
0·46 
0·63 
 
1·91 
3·34 
 
0·853 
0·389 
Household asset index 0·77 0·62 0·96 0·020 
Global test of proportional hazards: 0·665 
Infants eligible for inclusion in this sensitivity analysis: Survived = 27,718, died = 77 
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2.4 Any dose of RV versus 0 doses (10 week cohort inclusion) 
Variable 
Hazard 
Ratio 
95% Confidence 
Interval 
p-value 
RV status 0 doses 
≥1 dose 
1·00 
0·62 
 
0·32 
 
1·20 
 
0·156 
Mother’s status Married 
Single 
Divorced/widow 
Deceased 
1·00 
1·87 
1·42 
94·73 
 
0·95 
0·65 
37·47 
 
3·68 
3·14 
239·49 
 
0·071 
0·382 
<0·001 
Mother’s education None 
Primary 
Secondary/Tertiary 
1·00 
1·43 
1·48 
 
0·70 
0·60 
 
2·89 
3·66 
 
0·324 
0. ·393 
Water source                  
 
Protected source 
Open source 
1·00 
1·56 
 
0·99 
 
2·44 
 
0·053 
Toilet facility None 
Some facility 
1·00 
1·24 
 
0·73 
 
2·12 
 
0·422 
House quality Worst 
Middle 
Best 
1·00 
0·90 
1·65 
 
0·47 
0·83 
 
1·71 
3·28 
 
0·740 
0·151 
Household asset index 0·77 0·63 0·93 0·006 
Global test of proportional hazards: 0·779 
Infants eligible for inclusion in this sensitivity analysis: Survived = 28,012, died = 101 
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2.5 All-cause non-traumatic mortality (10 week cohort inclusion) 
Variable 
Hazard 
Ratio 
95% Confidence 
Interval 
p-value 
RV status 0 doses 
2 doses 
1·00 
0·29 
 
0·22 
 
0·38 
 
<0·001 
Mother’s status Married 
Single 
Divorced/widow 
Deceased 
1·00 
2·27 
1·97 
49·13 
 
1·59 
1·33 
24·25 
 
3·23 
2·92 
99·56 
 
<0·001 
0·001 
<0·001 
Mother’s education None 
Primary 
Secondary/Tertiary 
1·00 
1·02 
0·75 
 
0·73 
0·45 
 
1·45 
1·24 
 
0·89 
0·26 
Water source                  
 
Protected source 
Open source 
1·00 
1·27 
 
0·98 
 
1·65 
 
0·07 
Toilet facility None 
Some facility 
1·00 
1·27 
 
0·95 
 
1·71 
 
0·11 
House quality Worst 
Middle 
Best 
1·00 
0·79 
1·15 
 
0·54 
0·74 
 
1·14 
1·79 
 
0·21 
0·53 
Household asset index 0·83 0·74 0·92 0·001 
Global test of proportional hazards: 0·0002 (ie PH assumption is rejected) 
Infants eligible for inclusion in this sensitivity analysis: Survived = 27,912, died = 317 
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Appendix 3: Socio-demographic status, Site 1. 
 
3.1 Socio-demographic characteristics of children according to vaccination status 
Variable 
0 doses 1 dose 2 doses 
N (%) N (%) N (%) 
TOTAL 1,750 603 25,831 
Mother died 3 (0.2%) 0  (0%) 22 (0.1%) 
Marital status:  
Married 
Single 
Divorced/widow 
1,536 
95 
114 
(88%) 
(5%) 
(7%) 
541 
33 
28 
(90%) 
(5%) 
(5%) 
23,273 
1,406 
1,133 
(90%) 
(5%) 
(5%) 
Education: 
None 
Primary 
Secondary 
260 
1,341 
148 
(15%) 
(77%) 
(8%) 
103 
447 
52 
(17%) 
(74%) 
(9%) 
2,762 
19,771 
3,285 
(11%) 
(77%) 
(13%) 
Water source                  
Open source 
Protected source 
444 
1,304 
(25%) 
(75%) 
129 
474 
(21%) 
(79%) 
4,523 
21,308 
(18%) 
(82%) 
Toilet facility 
No facility 
Some facility 
394 
1,354 
(23%) 
(77%) 
139 
464 
(23%) 
(77%) 
4,561 
21,268 
(18%) 
(82%) 
House quality 
Worst 
Middle 
Best 
1,399 
234 
115 
(80%) 
(13%) 
(7%) 
471 
80 
52 
(78%) 
(13%) 
(9%) 
19,675 
3,906 
2,247 
(76%) 
(15%) 
(9%) 
 Mean (SD) Mean (SD) Mean (SD) 
Mother’s age 27·6 (6·76) 27·7 (7·30) 27·0 (6·58) 
Household assets 1·33 (1·15) 1·36 (1·15) 1·55 (1·18) 
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3.2 Socio-demographic characteristics of entire cohort over time 
 Year 
Socio-demographic factor 2012 2013 2014 2015 
Any toilet facility 78·4% 79·9% 83·4% 85·1% 
Household mobile phone ownership 38·5% 42·0% 44·6% 50·1% 
No maternal education 13·6% 11·8% 10·4% 9·4% 
Maternal primary education 74·2% 75·7% 77·3% 78·5% 
Maternal secondary / tertiary education 11·8% 12·3% 12·3% 12·1% 
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Appendix 4: Vaccine status construction 
 
There are three sources of vaccine status information available in Malawi:  
- Health passports (government issued caregiver-held documents) 
- Caregiver recall  
- Under 1 government vaccine registers (filled by healthcare workers at the point of vaccination and 
stored in frontline health facilities) 
 
Health passports were witnessed at home-visit interviews at 4 months and 1 year of age and at verbal autopsy 
interviews. Degree of reliability was then assigned to vaccine data source as outlined in the table, including 
relative merits of each source. 
 
4.1 Vaccine data source reliability 
Data Source Strengths Weaknesses Reliability 
Health passport 
• Filled in at the point of vaccination 
• Dates included 
• Less than 5% mis-recording 
• Differential availability according to 
survival status 
High 
Under 1 register 
• Routine data, therefore should be 
available for all, irrespective of 
survival status 
• Some registers are missing or of very 
poor quality 
• Issues in tracing children through 
registers and across facilities 
• Absence of record does not mean they 
are unvaccinated 
Medium 
Caregiver recall with 
known dates 
• Dates included 
• Generally some documented evidence 
provided e.g. twins health passport 
• Uncommon High 
Caregiver recall of no 
vaccinations 
• Generally anecdotal support which 
makes it believable  
• Uncommon 
• Relies on accurate recall  
High 
Caregiver recall 
• Available for most children, regardless 
of survival status 
• Recall bias and social-desirability bias 
(in both directions), so hard to adjust for 
the uncertainty 
• Chance of interviewer bias  
Low 
 
The following hierarchical rules were applied to construct a binary variable indicating vaccine received or vaccine 
not received:  
1. If at home visit interview or VA a vaccine is recorded as ‘received’ in the health passport, this information 
will be taken as correct. 
2. If at home visit interview or VA a vaccine is recorded as ‘not received’ or ‘missing’, or where no health 
passport was seen: 
a. If available, the vaccine status from a health passport at any prior 4-month interview (if such 
occurred) will be used 
b. If vaccines have been recorded in the under 1 register with evidence of a date of vaccination, 
this vaccine status will be used 
c. If vaccine status is not determined by 1, 2a or 2b then caregiver report will be used. 
3. In case of data conflict between 4-month visit, 1 year old visit, under-1 register or maternal report, 
information from the health passport will be prioritised, followed by under 1 register and then caregiver 
report.  
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Appendix 5: Smoothing of mortality over time in Figure 2 
Figure 2 Panel A. shows locally weighted scatterplot smoothing function of all-cause and diarrhoea-associated 
mortality in 10-51 week old infants from Site 1 as implemented by Stata 13.1 on basis of Cleveland, W. S. 1979. 
Robust locally weighted regression and smoothing scatterplots. Journal of the American Statistical Association 
74:  829-836. 
 
Figure 2 Panel B. shows the 12-month locally weighted moving average smoothing function of all-cause and 
diarrhoea-associated mortality in 10-51 week old infants from Site 2. The longer duration of data prior to 
vaccine introduction allowed us to use 12-month weighting to demonstrate the trend over years. The function 
was defined as follows:  
?̂?𝑡 =
1
24
(𝑌𝑡−6 + 𝑌𝑡+6) +
1
12
(𝑌𝑡 + 𝑌𝑡−1 + 𝑌𝑡+1 + 𝑌𝑡−2 + 𝑌𝑡+2 + 𝑌𝑡−3 + 𝑌𝑡+3 + 𝑌𝑡−4 + 𝑌𝑡+4 + 𝑌𝑡−5 + 𝑌𝑡+5) 
; where 𝑌𝑡 is the monthly observation at month t and ?̂?𝑡 is the locally-weighted estimate at month t. 
